WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC

Clinical trial NCT04644289 · RECRUITING

Trial details

NCT number: NCT04644289
Sponsor: AGO Research GmbH
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer

Start date: 2022-05-05
Primary completion: 2028-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.